MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced second quarter 2022 financial results. “We delivered a remarkable second quarter as we continue changing the standard of care for millions of […]
Other News
United Therapeutics Corporation Reports Second Quarter 2022 Financial Results
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter ended June 30, 2022. Total revenues in the second quarter of 2022 grew 5% year-over-year to $466.9 million, compared to $446.5 million in the second […]
Thubrikar Aortic Valve announces initial 30-day outcomes of CE Mark-enabling TAVI-1 Study
NORRISTOWN, Pa.–(BUSINESS WIRE)–Thubrikar Aortic Valve, Inc., announced today successful 30-day outcomes in the first two patients receiving the Optimum Transcatheter Aortic Valve (Optimum TAV™). The implantations were performed by the Principal Investigator, Jaroslaw Trebacz, MD, at the Specialty Hospital Jana Pawla II, Krakow, Poland. The study was approved by the […]
TransMedics Reports Second Quarter 2022 Financial Results
Accelerated Commercial Momentum to Achieve Net Revenue of $20.5 million 2022 Revenue Guidance Range Raised to $67 million to $75 million ANDOVER, Mass., Aug. 1, 2022 /PRNewswire/ — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today reported financial results for […]
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on July 29, 2022 it granted stock options to purchase an aggregate of 88,200 shares of common stock to 11 new employees, whose employment commenced in July 2022, as a material inducement to […]
FUJIFILM Sonosite is now the Exclusive Ultrasound Sponsor of The Resuscitative TEE Workshop
Bothell, WA, Aug. 02, 2022 (GLOBE NEWSWIRE) — FUJIFILM Sonosite, Inc. – the world leader in point-of-care ultrasound (POCUS) solutions – is now the exclusive ultrasound sponsor of The Resuscitative Transesophageal Echocardiography (TEE) Workshop, a prominent and globally active clinical education program presented by a multidisciplinary team of leaders in this emerging […]
Vektor Medical Bolsters Team to Accelerate Roll-Out of Computationally-Intelligent Technology
Arrhythmia innovator appoints strategic, AI and product executives as it ramps up commercial expansion SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, developer of the world’s first technology to rapidly map arrhythmias anywhere in the heart using only 12-lead ECG data, today announced the appointment of three key executives. The appointments, which come as […]
CORRECTING and REPLACING Soleo Health Selected as Limited Drug Distribution Partner for Administration of LEQVIO®
Company to Distribute Recent FDA-Approved Treatment for Reducing Bad Cholesterol CORRECTION…by Soleo Health August 01, 2022 07:17 PM Eastern Daylight Time FRISCO, Texas–(BUSINESS WIRE)–Headline of release dated July 26, 2022, should read: Soleo Health Selected as Limited Drug Distribution Partner for Administration of LEQVIO® The updated release reads: SOLEO HEALTH […]
Element Science Announces First Patient Save with Jewel Patch Wearable Cardioverter Defibrillator (P-WCD)
SAN FRANCISCO–(BUSINESS WIRE)–Element Science, an innovative health technology company pioneering a next-generation digital wearable platform for high-risk cardiovascular patients transitioning from hospital to home, today announced the first patient save from a successful defibrillation early in the enrollment of the Investigational Device Exception (IDE) Study of its Jewel Patch Wearable […]
Ra Medical Systems Provides Update on its Annual Filings
CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company) announces that its audited consolidated financial statements for the fiscal year ended December 31, 2021 included in the Company’s Form 10-K filed with the Securities and Exchange Commission (SEC) on March 24, 2022 and Amended Form […]



